News
The move bolsters the CDMO’s commitment to cell and gene therapy by incorporating advanced manufacturing and fill-finish ...
Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback